This is a match-making section for OHAMR Call for proposals 2026.
H - Human Health
medchem; ADMET; synthesis; Galleria mellonella
We employ a range of hit-identification strategies, including structure- and fragment-based drug design, virtual screening, high-throughput screening and a variety of biophysical methods. In addition, we pioneer innovative protein-templated techniques like dynamic combinatorial chemistry and kinetic target-guided synthesis, to address key bottlenecks in drug discovery. We use classical and innovative medicinal-chemistry approaches to design, synthesize and profile the most promising inhibitors, enabling efficient subsequent multiparameter optimization. Various in vitro and cell-based assays, the generation of in silico data, elucidation of the mode of action and the co-crystallization of selected compounds with their targets support the straightforward evaluation of novel anti-infectives and their further optimization. In the OH-AMR context we offer our expertise mentioned above, and in more detail, in medicinal chemistry, in vitro ADMET profiling, and in vivo Galleria mellonella models.
We would be delighted to contribute our expertise as outlined above and participate in an anti-infective project that requires expertise in areas such as medicinal chemistry, in vitro ADMET profiling, and/or in vivo Galleria mellonella models.
Submitted on 2025-12-02 07:38:44
« Return to the partner search tool